Comprehensive textbook covering all aspects of the care of patients with advanced heart or lung disease
Transplantation and Mechanical Support for End-Stage Heart and Lung Disease is the most comprehensive and contemporary textbook available that addresses the medical and surgical treatment options for patients with end-stage heart and lung disease. All facets of these complex and resource-intensive therapies are covered by leading experts - including the basics of transplant immunology, databases, regulatory and ethical aspects of transplantation and conventional and new modalities of donor organ harvest.
Transplantation and Mechanical Support for End-Stage Heart and Lung Disease includes further information on topics such as:
- Historical developments that facilitated heart and lung transplantation; engineering advances in continuous flow technologies
- Transplant organizations, oversight, structure, process, databases and registries in the thoracic transplants and MCS field
- Current strategies in immune modulation, desensitization protocols and mechanisms of allograft rejection and tolerance/immunosenescence
- Detailed descriptions of donor and recipient surgical procedures as well as comprehensive implantation techniques for all available short- and long-term mechanical circulatory support devices, including ECMO
- Organ allocation and prioritization, donor evaluation, high risk donors, marginal donors, and risk assessment
Richly enhanced with summary tables and color illustrations to provide an engaging and supportive learning experience, the book will serve as a highly valuable source of contemporary knowledge for medical students, residents, nurses, perfusionists, physicians and surgeons involved in the care of these desperately ill group of patients.
“This comprehensive book covers all aspects of advanced heart and lung failure treatment, including shock, short-term and durable mechanical assistance, as well as transplantation. The in-depth information will be welcome by newcomers in the field as well as seasoned veterans.”
- Andreas Zuckermann, M.D Vice-Chair, Department of Cardiac Surgery, Director of Cardiac Transplantation Program, Medical University of Vienna, Vienna General Hospital
“This comprehensive tour-de-force compendium covers practical issues of clinical administration, program development, care pathways, ongoing challenges and opportunities in each treatment area as a must go-to reference for guidance in the rapidly evolving fields of mechanical circulatory support and transplantation.”
- Mandeep R. Mehra, MBBS, MSc, FRCP Executive Director, Center for Advanced Heart Disease, Brigham and Women’s Hospital, Harvard Medical School
“This unique textbook authored by key opinion leaders is a refreshing 'wind of change' in our field, one that will well serve all professionals involved in the care of end-stage heart and lung patients for many years to come.”
- Marcelo Cypel MD, MSc, FACS, FRCSC Surgical Director Ajmera Transplant Centre at UHN, University of Toronto
Table of Contents
Section IX The MCS Patient 785
Stephan Schueler
56 Postoperative ICU Care for Mechanical Circulatory Support Patients 787
Nicholas C. Cavarocchi
57 Post-ICU LVAD Course 797
Melissa Lyle and Divya Gupta
58 The VAD Coordinator's Role: Education and Team Communication 805
Heidi Craddock and Christy Kay
59 The LVAD Patient Bridging to Wellness: Psychological Assessment and Rehabilitation 812
Mary Amanda Dew
60 LVAD Clinic: Outpatient Monitoring and Causes for Readmission 833
Nancy K. Sweitzer and Sophia Airhart
61 Hemodynamic Optimization of the LVAD Patient 849
Nikhil Narang, Gabriel Sayer, and Nir Uriel
62 Myocardial Recovery During LVAD Support 858
Christos P. Kyriakopoulos, Craig H. Selzman, and Stavros G. Drakos
Section X MCS-Related Complications in the Chronic Patient 881
Joseph G. Rogers
63 Right Heart Failure: Risk Scores and Management 883
Brent C. Lampert and Jeffrey J. Teuteberg
64 LVAD-Associated Acquired von Willebrand Syndrome and Gastrointestinal Bleeding: Pathophysiology, Etiologies, and Management 898
Sanjhai L. Ramdeen and Carlo R. Bartoli
65 Mechanical Circulatory Support Infections 907
Gerard Giblin, Ciara O’Connor, Emer Joyce, and Margaret M. Hannan
66 Pump Thrombosis: Medical and Surgical Management 932
Andrew Xanthopoulos, Filippos Triposkiadis, and Randall C. Starling
67 Neurologic Complications: Pathophysiology, Incidence, Types, Prevention, and Management 945
Paolo C. Colombo, Chinwe Ibeh, Kara R. Melmed, and Joshua Willey
68 Renal Dysfunction in MCS Patients: Perioperative and Long-Term Considerations 966
Natasha A. Vedage and Meredith A. Brisco-Bacik
69 De Novo Aortic Insufficiency 977
Jennifer Cowger
Section XI The LVAD Program and Future Directions 987
Daniel J. Goldstein
70 Regulatory and Miscellaneous Aspects of an LVAD Program 989
Christina Cheyne, Igor Gosev, and Sunil Prasad
71 Current Limitations and Characteristics of Next-Generation Ventricular Assist Devices 996
Yuji Kaku, Yoshifumi Naka, and Daniel Burkhoff
72 MCS and Novel Adjunctive Therapies: An Update 1011
Doris A. Taylor, Lourdes I. Chacon, Camila Hochman-Mendez, and Luiz C. Sampaio
73 Artificial Intelligence and Machine Learning in MCS 1021
Manreet Kanwar, Marek J. Druzdzel, Faezeh Movahedi, and Jim Antaki
Lung Transplant
Section XII The Pretransplant Phase: Recipient 1035
Mani A. Daneshmand
74 Recipient Selection and the Lung Transplant Window for Adult and Pediatric Patients 1037
David C. Neujahr and William R. Hunt
75 Advanced Lung Disease 1053
Cynthia Jane Gries
76 The Acute Lung Failure Patient and Temporary Mechanical Support 1070
Purav Shah, Maria C. Creel, and Satish Chandrashekaran
77 Preoperative Optimization for Lung Transplant 1081
Andrew M. Vekstein, John C. Haney, John M. Reynolds, and Jacob A.Klapper
78 Lung Transplant Waitlist Management 1089
Joshua B. Smith and Alice L. Gray
Section XIII The Pretransplant Phase: Donor 1101
Yaron D. Barac
79 Prioritization: Candidate Selection and Organ Allocation Systems 1103
Are Martin Holm andMatthew G. Hartwig
80 Donor Lungs Evaluation 1110
Louis Stein, Alex Leung, Yaron D. Barac, Mani A. Daneshmand, and Yuri Pesachovitz
81 Lung Transplantation: Marginal Donors and Risk Assessment 1119
Laura L. Donahoe and Shaf Keshavjee
82 Organ Procurement and Preservation 1132
Reshma Biniwale and Abbas Ardehal
83 Machines and Donation After Circulatory Death (DCD) in Lung Transplantation 1145
Gabriel Loor and Pablo Sanchez
Section XIV The Transplant Phase 1163
Mani A. Daneshmand
84 Components of the Lung Transplant Team 1165
Keshava Rajagopal
85 Anesthesia and Hemodynamic Management for Lung Transplantation 1167
Angela Pollak, Charles Overbeek, and Brandi Bottiger
86 Techniques in Lung Transplantation 1183
Maziar Khorsandi, Jeffrey Keenan, and Matthew Hartwig
87 Technical Considerations in the Complex Recipient 1193
Jamil F. Borgi and Stephen J. Forest
88 Taking the First Breath: ICU Care of the Lung Transplant Patient 1204
Daniel Herr and Patrick Odonkor
Section XV The Post-Transplant Phase 1215
Yaron D. Barac
89 Post-Transplant Phase: Issues in the Early Postoperative Period 1217
John Mackintosh and Peter Hopkins
90 Post-Transplant Phase: From ICU Discharge to Hospital Discharge 1240
Osnat Shtraichman and Mordechai R. Kramer
91 Lung Transplant Rejection 1268
Caroline Patterson and Martin Goddard
92 Transplant Infectious Diseases 1288
Grace Chan, Breda Lynch, Michelle Murray, and Margaret M. Hannan
93 Post-Transplant Complications 1317
Jagan Murugachandran, Debra Thomas, and Jasvir Parmar
94 Post-Transplant Other Adverse Events 1333
Andres Pelaez and Karoun H. Bagamian
95 Survival and Quality of Life Post Lung Transplantation 1345
Attawar Sandeep, Vijil Rahulan, and Unmil Shah
Section XVI Thoracic Transplant in a Long-Term Perspective 1359
Mani A. Daneshmand
96 The Future of Heart and Lung Transplantation 1361
Jane M.O., David C. Becerra, and Joren C. Madsen
97 Heart and Lung Xenotransplantation 1389
Jane O., Cynthia L. Miller, and Joren C. Madsen
Index 1404
